| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Advisory Services Fees In Franchising |
|
Advice You - Advisory Services Fees In Franchising
Often in franchising companies a franchisor will spend 80 percent of their time helping 20 perce According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nt of their franchises. The allocation of the franchisor’s labor will be disproportionate and i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in n effect on fair to the superstar performing franchise outlets in the franchising system. There lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. are also times when a franchisee will have needs that our way beyond the call of duty and those here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe requirements of the franchisor in the franchising agreement. It is for this reason, especially d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro with our international franchises that I decided to add a clause into our franchise agreements, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc which protected our cash flow and time management all of our consultants, employees and staff. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Below is a copy of the clause that I put into our franchising agreements; 4.4 Advisory Service nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s Franchisor may provide, as and to the extent required in Franchisor’s judgement, a continuing and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ advisory service, which may include consultation on promotional, marketing and advertising tech ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi niques and customer relations. Representatives of Franchisor may consult regularly with Franchis ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ee at no cost to the Franchisee. At Franchisee’s request, a representative of Franchisor may vis dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod it the Franchised Business at least once each year at a time mutually agreed upon. Field represe cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ntatives may be available at Franchisee’s request for extraordinary consultation and assistance tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen on a fee basis by appointment only. Franchisor’s current fee for extraordinary assistance is U.S t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel $250 per day, plus all related expenses and may be increased by Franchisor. -- -- --- --- --- ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust --- -- -- It may be necessary for franchisors to address such issues in their franchising agree y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ments, prior to running up against the problem or potential eventuality. It is recommended ther . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de efore that every franchising company contact their franchise attorney and discuss this issue. I elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip hope if you are in franchising you can learn from my school hard knocks. Consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Bad Answers/Good Answers: Discussing Teamwork In An Interview Yesterday's Project Manager is Today's Project Engineer Change Management Issues in the Truck Wash Business
|